Form 4: 180 Life Sciences Director Lawrence Steinman Acquires 65,000 Shares of Common Stock

Director Lawrence Steinman acquired 65,000 shares of 180 Life Sciences Corp. common stock on February 20, 2025, as compensation for services.

Summary

• On February 20, 2025, Lawrence Steinman, a director of 180 Life Sciences Corp., acquired 65,000 shares of common stock.
• The acquisition was made as compensation for services rendered and to be rendered to the Issuer as a member of the Board of Directors.
• The shares were issued under the Issuer's 2022 Equity Compensation Plan and are subject to time-based vesting.
• Half of the shares will vest on July 1, 2025, and the remaining half on December 31, 2025, contingent upon continued service to the Issuer.
• Following the transaction, Steinman directly owns 67,534 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, indicating confidence in the company. The vesting schedule further aligns the director's interests with the long-term success of the company.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The vesting schedule incentivizes continued service and commitment from the director.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a standard disclosure of stock ownership changes by a company insider, which is common in the biotech industry. It provides transparency to investors regarding the alignment of interests between management and shareholders.

Stakeholder Impact

• Shareholders may view the director's stock acquisition positively, as it signals confidence in the company's prospects.
• The vesting schedule incentivizes the director to remain committed to the company's success, which benefits all stakeholders.

Key Dates

Keywords

180 Life Sciences Corp, Lawrence Steinman, Director, Common Stock, Acquisition, Equity Compensation, Beneficial Ownership, Form 4, ATNF